Arcutis Canada's Roflumilast Foam 0.3% Advances in Health Canada Submission for Seborrheic Dermatitis Treatment
Jan 9, 2024
Healthcanada Investment Portfolios
Health Canada Grants Approval to LITFULO™ as First Severe Alopecia Areata Treatment in Canada
Dec 5, 2023